Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.975 USD | +6.21% |
|
+15.82% | +16.12% |
08/07 | Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug | MT |
01/07 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to Russell Small Cap Comp Value Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.12% | 198M | |
+25.30% | 46.56B | |
+45.43% | 41.67B | |
-0.39% | 41.16B | |
+34.35% | 32.4B | |
+20.84% | 28.18B | |
-6.35% | 28.1B | |
+49.23% | 14.52B | |
+47.84% | 13.74B | |
+1.84% | 12.17B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- Transcript : Outlook Therapeutics, Inc. - Special Call